![Thomas Nifong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Nifong
Corporate Officer/Principal presso Definiens AG
Profilo
Thomas Nifong is currently working as the Executive Vice President-Predictive Tests at Definiens AG.
Previously, he worked as the Vice President-Clinical Operations at Metamark Genetics, Inc. and as a Process Engineer at Unilever UK Ltd.
Dr. Nifong holds a doctorate degree from the University of Rochester and an undergraduate degree from Purdue University.
Posizioni attive di Thomas Nifong
Società | Posizione | Inizio |
---|---|---|
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01/01/2014 |
Precedenti posizioni note di Thomas Nifong
Società | Posizione | Fine |
---|---|---|
Unilever UK Ltd.
![]() Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formazione di Thomas Nifong
Purdue University | Undergraduate Degree |
Rochester Christian University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Unilever UK Ltd.
![]() Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Consumer Non-Durables |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
- Borsa valori
- Insiders
- Thomas Nifong